Tabung, Fred K.
Steck, Susan E.
Liese, Angela D.
Zhang, Jiajia
Ma, Yunsheng
Johnson, Karen C.
Lane, Dorothy S.
Qi, Lihong
Snetselaar, Linda
Vitolins, Mara Z.
Ockene, Judith K.
Hebert, James R.
Funding for this research was provided by:
National Cancer Institute (F31CA177255, K05CA136975)
National Institutes of Health (HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C)
Article History
Received: 4 April 2016
Accepted: 20 July 2016
First Online: 30 July 2016
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: Dr. James R. Hébert owns controlling interest in Connecting Health Innovations LLC (CHI), a company planning to license the right to his invention of the dietary inflammatory index (DII) from the University of South Carolina in order to develop computer and smart phone applications for patient counseling and dietary intervention in clinical settings.